Overweight children may have increased risk of esophageal cancer as adults
the ONA take:
According to a new study published in the British Journal of Cancer, researchers have found that overweight children may have an increased risk for esophageal cancer when grow up compared with slimmer children.
For the study, researchers analyzed the health records of over 255,000 Danish children born between 1930 and 1971 who had their height and weight measured every year between the ages of 7 and 13. Of those, over 250 developed esophageal cancer over the age of 40.
Results showed that children aged 9 to 13 with a higher body mass index (BMI) that made them more likely to be overweight or obese had an increased risk for developing esophgeal cancer later in life.
The researchers estimate that 2.1% of esophageal cases in adult Danish men may be a result of being overweight or obese at the age of 13. They also estimate that the percentage of overweight- or obesity-related cases could increase to 17.5% of all esophageal cancer cases due to the increase in childhood obesity.
The findings suggest the importance of ensuring that children eat healthy diets and have active lifestyles in order to reduce the risk of developing cancer in the future.
Overweight children may have an increased risk for esophageal cancer when grow up compared with slimmer children.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- Ruxolitinib: A Targeted Treatment Option for Patients with Polycythemia Vera
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Robotic Surgery Provides Good Outcomes and Survival in Oropharyngeal Cancer
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- Ruxolitinib Effective as Long-term Treatment Option for Polycythemia Vera
- Definitive IMRT Associated With Shorter Feeding Tube Placement Duration in HNC
- SBRT Improves Overall and Disease-Specific Survival in Stage I NSCLC
- Patients Receiving RT in APBI Facilities Despite Eligibility for Observation
- Prolonged Imatinib Therapy Improves Likelihood of Deeper Molecular Response
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|